Literature DB >> 6483850

Animal models of depression: an overview.

W T McKinney.   

Abstract

Although animal models cannot replicate human psychopathology in every detail, they should properly be conceived as experimental systems in which selected and specific questions can be investigated in ways impossible to do in humans. In considering the general kinds of animal models, distinctions must be drawn among those designed to simulate specific signs or symptoms, those designed to test a specific etiological theory, those designed to study underlying behavioral and neurobiological mechanisms, and those whose principal purpose is to permit pre-clinical drug evaluation. If, for example, drug evaluation is the first concern, the empirical validity of the model in predicting the therapeutic efficacy of drugs is primary, whereas the mechanisms responsible for inducing the syndrome, and behavioral similarity issues become secondary. The available models of depression are reviewed in the light of their specific advantages and limitations, including those induced pharmacologically, maternal and peer separation, learned helplessness, chronic stress, changes in dominance hierarchy, intra-cranial self-stimulation, conditioned motionlessness and behavioral despair models. Since multiple variables are involved in the etiology of depressions, animal models offer the possibility of evaluating their main effects and interactions in a controlled prospective manner. While caution is required in cross-species reasoning, there are nevertheless guidelines, and the continuing development of a comparative approach in Psychiatry has great potential.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6483850

Source DB:  PubMed          Journal:  Psychiatr Dev        ISSN: 0262-9283


  16 in total

Review 1.  Behavioral and neurobiological characteristics of social stress versus depression in nonhuman primates.

Authors:  Carol A Shively; Stephanie L Willard
Journal:  Exp Neurol       Date:  2011-09-24       Impact factor: 5.330

Review 2.  Genetic and pharmacological models of cholinergic supersensitivity and affective disorders.

Authors:  D H Overstreet; R W Russell; A D Crocker; J C Gillin; D S Janowsky
Journal:  Experientia       Date:  1988-06-15

3.  Screening antidepressants in the chick separation-stress paradigm.

Authors:  Matthew W Feltenstein; Kenneth J Sufka
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  Dihydrotestosterone differentially modulates the cortisol response of the hypothalamic-pituitary-adrenal axis in male and female rhesus macaques, and restores circadian secretion of cortisol in females.

Authors:  Donna J Toufexis; Mark E Wilson
Journal:  Brain Res       Date:  2011-10-25       Impact factor: 3.252

5.  Social behavior effects of diphenyl dimethyl bicarboxylate (DDB) in the sensory contact model.

Authors:  Amal M Mahfoz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-28       Impact factor: 3.000

Review 6.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

7.  Strain differences in fatigue and depression after experimental stroke.

Authors:  Allison Kunze; Dannielle Zierath; Olga Drogomiretskiy; Kyra Becker
Journal:  Transl Stroke Res       Date:  2014-06-12       Impact factor: 6.829

8.  Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.

Authors:  Kimberly R Tyeryar; Ashiwel S Undie
Journal:  Psychopharmacology (Berl)       Date:  2007-04-15       Impact factor: 4.415

9.  Simulating the anhedonia symptom of depression in animals.

Authors:  Jean-Luc Moreau
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

Review 10.  Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder.

Authors:  Richard McCarty; Travis Josephs; Oleg Kovtun; Sandra J Rosenthal
Journal:  Transl Psychiatry       Date:  2021-07-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.